Detalles de la búsqueda
1.
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation.
Ann Hematol
; 102(7): 1915-1925, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37079070
2.
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.
Support Care Cancer
; 31(6): 350, 2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37227523
3.
Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience.
Support Care Cancer
; 30(1): 585-591, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347181
4.
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.
Ann Hematol
; 99(2): 331-341, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853703
5.
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.
Ann Hematol
; 99(4): 867-875, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32036421
6.
Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.
Transfus Apher Sci
; 59(6): 102911, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32859502
7.
Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34+ Cell and Platelet Counts.
Biol Blood Marrow Transplant
; 25(8): 1586-1591, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31002994
8.
A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model.
Biol Blood Marrow Transplant
; 24(3): 608-613, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29032271
9.
Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after highdose melphalan and autologous stem cell transplantation.
Ann Hematol
; 102(8): 2297-2298, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37347271
10.
High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study.
Biol Blood Marrow Transplant
; 21(11): 1932-8, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099830
11.
Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.
Biol Blood Marrow Transplant
; 21(5): 881-8, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25636377
12.
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study.
Biol Blood Marrow Transplant
; 20(7): 1026-32, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24699116
13.
Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies.
Biol Blood Marrow Transplant
; 18(10): 1600-7, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22484666
14.
A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease.
Haematologica
; 97(10): 1532-8, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22491736
15.
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide.
Bone Marrow Transplant
; 57(12): 1758-1764, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36057732
16.
Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.
Expert Opin Biol Ther
; 22(3): 407-421, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463175
17.
The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient Transplantation.
Clin Lymphoma Myeloma Leuk
; 21(4): e402-e409, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33288484
18.
Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report.
Front Oncol
; 10: 967, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32626658
19.
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.
Blood Adv
; 4(16): 3900-3912, 2020 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32813875
20.
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials.
Expert Rev Hematol
; 12(8): 665-684, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31251688